
Unlocking the Mysteries of Limb-Girdle Muscular Dystrophy Due to POMK Deficiency
Explore the genetic intricacies of Limb-Girdle Muscular Dystrophy due to POMK deficiency. Learn about diagnosis, genetic testing, and potential treatments.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore the genetic intricacies of Limb-Girdle Muscular Dystrophy due to POMK deficiency. Learn about diagnosis, genetic testing, and potential treatments.

Uncover the role of genetic testing in diagnosing LIPE-related familial partial lipodystrophy. Explore the impact of mutations on fat distribution and metabolism.

Explore the genetic landscape of Lissencephaly 6 with Microcephaly, highlighting the role of genetic testing in early diagnosis, personalized treatment, and family planning.

Explore how genetic testing revolutionizes the diagnosis and treatment of Lymphatic Malformation 4, offering insights for personalized medicine and improved outcomes.

Explore how genetic testing unravels early-onset macular degeneration, offering predictive insights, tailored treatments, and informed family planning decisions.

Explore how genetic testing revolutionizes the diagnosis and management of macular dystrophy with central cone involvement, offering personalized treatment and early intervention.

Explore the role of genetic testing in diagnosing MPPH2, a rare disorder. Understand early detection, personalized treatment, and family planning benefits.

Explore the complexities of MPPH Syndrome 3, a rare genetic disorder linked to CCND2 mutations. Learn how genetic testing aids in diagnosis and personalized care.